The Centers for Disease Control and Prevention (CDC) has forecasted a funding opportunity titled "Promoting Self-Management to Reduce Morbidity in the Blood Disorder Community Using Evidence-Based Programs" under the opportunity number CDC-RFA-DD-25-0121. This initiative aims to reduce morbidity and mortality associated with blood disorders by supporting evidence-based self-management programs. The blood disorders targeted in this program include hemophilia, von Willebrand disease (VWD), venous thromboembolism (VTE), and thalassemia, which are divided into three components for applicants to choose from.
The primary objectives of this funding opportunity are to:
1. Identify a specific target population, such as individuals diagnosed with a blood disorder (children/adolescents or adults), caregivers, or healthcare providers.
2. Promote health knowledge and literacy related to blood disorders and treatments among the target population.
3. Adapt evidence-based self-management programs to address gaps in knowledge, behavioral skills, values, and barriers to self-management.
4. Implement and evaluate these programs.
5. Provide innovative, evidence-based training to healthcare providers to enhance shared decision-making and improve medication adherence.
The total estimated funding for this opportunity is $3,555,000, with individual awards ranging between $150,000 and $450,000. The CDC anticipates making four awards, with an estimated project start date of September 30, 2025. Eligible applicants include state and local governments, tribal governments, nonprofits, educational institutions, for-profit organizations, and others listed in the eligibility criteria.
Applications will be due by May 16, 2025, and successful applicants can expect an award date of September 1, 2025.
For more information or inquiries, potential applicants can contact Fiona Bethea, PhD, MPH, at gvu0@cdc.gov or 404-639-4033.
